Results Of TAK-788 Trial: Among 28 Patients That Were Enrolled 43% Had A Response, PFS Was 7.3 Months, Drug Was Well Tolerated Overall - 102337

Spotlight
Video

Results Of TAK-788 Trial: Among 28 Patients That Were Enrolled 43% Had A Response, PFS Was 7.3 Months, Drug Was Well Tolerated Overall

Loading........
Description: Joel Neal MD Of Stanford University Medical Center Discusses Results Of TAK-788 Trial: Among 28 Patients That Were Enrolled 43% Had A Response, PFS Was 7.3 Months, Drug Was Well Tolerated Overall.
Shared By : Annual-Meeting
Posted on : 06/05/19
Added : 10 days ago